Adam Kalbermatten
Fortuna: 1 M $ al 31/07/2026
Fortuna: 1 M $ al 31/07/2026
Adam Kalbermatten is President & Chief Executive Officer at KORU Medical Systems, Inc. since 2026.
Formerly, Mr. Kalbermatten was VP & GM-Advanced Drug Delivery Systems at Becton, Dickinson & Co. Education includes undergraduate and graduate degrees from Stevens Institute of Technology and an MBA from Columbia Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 28/07/2026 | 362.017 ( 0,79 % ) | 1 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| KORU MEDICAL SYSTEMS, INC. | Director Ejecutivo | 01/07/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01/07/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Becton, Dickinson & Co.
Becton, Dickinson & Co. Medical SpecialtiesHealth Technology Manufactures and sells medical supplies, devices, laboratory equipment & diagnostic products | Health Technology |
KORU Medical Systems, Inc.
KORU Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and distributes portable medical devices | Health Technology |
Stevens Institute of Technology
Stevens Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.